Treatment-Related Neurotoxicity
- 1 August 2005
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 19 (4) , 729-738
- https://doi.org/10.1016/j.hoc.2005.05.010
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962Journal of Clinical Oncology, 2003
- CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin’s lymphomaInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS LymphomaJournal of Clinical Oncology, 2000
- Neurological complications of radiotherapy and chemotherapyZeitschrift für Neurologie, 1998
- Long-term survival in primary CNS lymphoma.Journal of Clinical Oncology, 1998
- High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.Journal of Clinical Oncology, 1998
- Primary central nervous system lymphoma: Treatment with chemotherapy and radiotherapyEuropean Journal Of Cancer, 1995
- The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression [see comments]Blood, 1995
- Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcomeJournal of Neurosurgery, 1994
- Radiation‐induced dementia in patients cured of brain metastasesNeurology, 1989